Latham & Watkins advised Essex Property Trust on the deal. Essex Property Trust, Inc.’s (NYSE: ESS) operating partnership, Essex Portfolio, L.P. closed an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Extra Space Storage on the offering. Extra Space Storage Inc. (NYSE: EXR), a leading owner and operator of self-storage facilities in the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised OneStream on the offering, Jones Day advised Kohlberg Kravis Roberts & Co. L.P. (“KKR”) and Latham & Watkins advised the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Avidity Biosciences, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Cooley...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Essex Property, while Alston & Bird represented an underwriting syndicate led by Wells Fargo, JP Morgan, PNC Capital Markets LLC, US Bancorp,...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represents Jefferies LLC and Leerink Partners LLC acting as placement agents in the financing. Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises HilleVax on Pricing of Public Offering of Common Stock. HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux, and Latham & Watkins advised the underwriter on the offering. Janux Therapeutics, Inc. (Nasdaq: JANX) has announced the pricing of an underwritten offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock. Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters. Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public...
You must be a Standard 1 Year member to access this content.
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
You must be a Standard 1 Year member to access this content.
